When G20 finance ministers meet in Venice on 9-10 July, they should adopt a plan to immunise the world against COVID-19. Every vaccine-producing country will be in the room: the United States (US), the United Kingdom (UK), the European Union (EU), China, Russia, and India. Together, these countries produce enough doses to complete the immunisation process for the entire globe by early 2022. Yet the world still lacks a plan to get it done.

The United States (US) led calls at a G20 meeting Tuesday for greater global cooperation in light of the coronavirus crisis as China insisted that multilateralism should not just be a slogan.Italy welcomed foreign ministers of the Group of 20 major economies to the southern city of Matera for their first in-person talks since the start of the pandemic that has claimed nearly four million lives worldwide.In a sharp reversal in tone from the previous US administration, Secretary of State Antony

The latest G7 summit was a waste of resources. If it had to be held at all, it should have been conducted online, saving time, logistical costs, and airplane emissions. But, more fundamentally, G7 summits are an anachronism.

Coronavirus vaccine producers promised billions of doses for poorer countries at a G20 health summit Friday, where leaders vowed to expand access to jabs as the only way to end the pandemic.The bosses of Pfizer, Moderna and Johnson & Johnson announced they would supply around 3.5 billion vaccine doses at cost or discount to low- and middle-income countries this year and next.Meanwhile the European Union (EU) pledged to donate 100 million doses and invest in regional manufacturing hubs

This November will mark the 20th anniversary of the BRIC acronym that I coined to capture the economic potential of Brazil, Russia, India, and China.

The world is not yet sufficiently alarmed by how much the COVID-19 pandemic has ravaged the global economy. We track the daily numbers of infections and casualties. But we are oblivious to the job losses and lives upended, especially in the developing world, where the pandemic has barely elicited a public-health response.The pandemic’s impact on major economies has so far been four times worse than that of the 2008 global financial crisis.

The inevitable rise of China as a global power that is increasingly challenging the supremacy and hegemony of the United States (US) both in the Asia Pacific and the world has been one of the dominant issues that has received a great deal of media coverage. Both locally and internationally, it continuously predominates attention in foreign policy circles and among local and international academics and experts of international relations and global politics. And in as far this

There is a great global misalignment: at the very moment cooperation is more vital than ever to address urgent challenges, it is in decline. In late June, referencing the fractured response to the COVID-19 crisis, United Nations (UN) Secretary-General Antonio Guterres warned “there is total lack of coordination among countries.” Some have gone further, drawing on examples from history and comparing the global quest for a COVID-19 vaccine to the space race between the United

As the world struggles to contain the COVID-19 pandemic and mitigate its impact on our lives and livelihoods, it should be clear to everyone that international cooperation is the only effective way to win the battle. National responses are vital, but in the medium term, multilateralism will be our best weapon in this fight – and our best defence against future global threats.My country, Spain, is on the front lines of the pandemic.

The COVID-19 pandemic has cast a pall over the global economy, making it impossible to anticipate even the near future. Restrictions on cross-border movements, along with national lockdowns, are rapidly reducing global production and consumption, and disrupting value chains. Growing uncertainties are creating a vicious circle, as the contraction in the real economy spills over into the financial sector, in turn reducing credit to non-financial firms.